237 related articles for article (PubMed ID: 20931557)
1. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
Yang X; Haurigot V; Zhou S; Luo G; Couto LB
Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
[TBL] [Abstract][Full Text] [Related]
2. Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection.
Yang X; Marcucci K; Anguela X; Couto LB
Mol Ther; 2013 Mar; 21(3):588-601. PubMed ID: 23295950
[TBL] [Abstract][Full Text] [Related]
3. Alleviation of off-target effects from vector-encoded shRNAs via codelivered RNA decoys.
Mockenhaupt S; Grosse S; Rupp D; Bartenschlager R; Grimm D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4007-16. PubMed ID: 26170322
[TBL] [Abstract][Full Text] [Related]
4. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs.
Huang H; Zhang C; Wang B; Wang F; Pei B; Cheng C; Yang W; Zhao Z
J Virol; 2018 Sep; 92(18):. PubMed ID: 29997205
[TBL] [Abstract][Full Text] [Related]
5. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
Bourhill T; Arbuthnot P; Ely A
J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
[TBL] [Abstract][Full Text] [Related]
6. Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication.
Mandal A; Chaubey B
Intervirology; 2018; 61(2):79-91. PubMed ID: 30253401
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of hepatitis C virus replication by miR-196a using lentiviral vectors.
Shafaati M; Jamalidoust M; Kargar M; Arefian E; Kafilzadeh F
Microbiol Immunol; 2021 Apr; 65(4):161-170. PubMed ID: 33470443
[TBL] [Abstract][Full Text] [Related]
8. In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapy.
Lavender H; Brady K; Burden F; Delpuech-Adams O; Denise H; Palmer A; Perkins H; Savic B; Scott S; Smith-Burchnell C; Troke P; Wright JF; Suhy D; Corbau R
Antimicrob Agents Chemother; 2012 Mar; 56(3):1364-75. PubMed ID: 22203606
[TBL] [Abstract][Full Text] [Related]
9. RNA interference inhibitors of hepatitis B virus.
McCaffrey AP
Ann N Y Acad Sci; 2009 Sep; 1175():15-23. PubMed ID: 19796073
[TBL] [Abstract][Full Text] [Related]
10. Development of gene therapy for treatment of age-related macular degeneration.
Askou AL
Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666
[TBL] [Abstract][Full Text] [Related]
11. Safe, long-term hepatic expression of anti-HCV shRNA in a nonhuman primate model.
Suhy DA; Kao SC; Mao T; Whiteley L; Denise H; Souberbielle B; Burdick AD; Hayes K; Wright JF; Lavender H; Roelvink P; Kolykhalov A; Brady K; Moschos SA; Hauck B; Zelenaia O; Zhou S; Scribner C; High KA; Renison SH; Corbau R
Mol Ther; 2012 Sep; 20(9):1737-49. PubMed ID: 22735378
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HCV replication by small interfering RNA.
Ray RB; Kanda T
Methods Mol Biol; 2009; 510():251-62. PubMed ID: 19009267
[TBL] [Abstract][Full Text] [Related]
13. A multiplexed miRNA and transgene expression platform for simultaneous repression and expression of protein coding sequences.
Seyhan AA
Mol Biosyst; 2016 Jan; 12(1):295-312. PubMed ID: 26617199
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cell-to-cell transmission of small silencing RNA can extend the therapeutic reach of RNA interference (RNAi).
Pan Q; Ramakrishnaiah V; Henry S; Fouraschen S; de Ruiter PE; Kwekkeboom J; Tilanus HW; Janssen HL; van der Laan LJ
Gut; 2012 Sep; 61(9):1330-9. PubMed ID: 22198713
[TBL] [Abstract][Full Text] [Related]
15. Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo.
Pihlmann M; Askou AL; Aagaard L; Bruun GH; Svalgaard JD; Holm-Nielsen MH; Dagnaes-Hansen F; Bek T; Mikkelsen JG; Jensen TG; Corydon TJ
J Gene Med; 2012 May; 14(5):328-38. PubMed ID: 22438271
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes.
Henry SD; van der Wegen P; Metselaar HJ; Tilanus HW; Scholte BJ; van der Laan LJ
Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906
[TBL] [Abstract][Full Text] [Related]
17. Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons.
Jarczak D; Korf M; Beger C; Manns MP; Krüger M
FEBS J; 2005 Nov; 272(22):5910-22. PubMed ID: 16279954
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA 130a Regulates both Hepatitis C Virus and Hepatitis B Virus Replication through a Central Metabolic Pathway.
Duan X; Li S; Holmes JA; Tu Z; Li Y; Cai D; Liu X; Li W; Yang C; Jiao B; Schaefer EA; Fusco DN; Salloum S; Chen L; Lin W; Chung RT
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321333
[TBL] [Abstract][Full Text] [Related]
19. Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.
Borel F; Kay MA; Mueller C
Mol Ther; 2014 Apr; 22(4):692-701. PubMed ID: 24352214
[TBL] [Abstract][Full Text] [Related]
20. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection.
Pan Q; de Ruiter PE; von Eije KJ; Smits R; Kwekkeboom J; Tilanus HW; Berkhout B; Janssen HL; van der Laan LJ
FEBS Lett; 2011 Apr; 585(7):1025-30. PubMed ID: 21376045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
